Steve Elms's Net Worth

$812 Million

Who is Steve Elms?

Steve Elms has an estimated net worth of $812 Million. This is based on reported shares across multiple companies, which include MAP Pharmaceuticals, Inc., Zeltiq Aesthetics Inc, CEMPRA, INC., ViewRay, Inc., Zosano Pharma Corp, Esperion Therapeutics, Inc., ADMA BIOLOGICS, INC., Loxo Oncology, Inc., AGILE THERAPEUTICS INC, Elevation Oncology, Inc., Syros Pharmaceuticals, Inc., Cidara Therapeutics, Inc., T2 Biosystems, Inc., TRANSENTERIX INC., SUNESIS PHARMACEUTICALS INC, Durata Therapeutics, Inc., Versartis, Inc., Marker Therapeutics, Inc., AMBIT BIOSCIENCES CORP, PERNIX THERAPEUTICS HOLDINGS, INC., INTERPHARM HOLDINGS INC, and Adams Respiratory Therapeutics, Inc..

SEC CIK

Steve Elms's CIK is 0001250195

Past Insider Trading and Trends

2014 was Steve Elms's most active year for acquiring shares with 22 total transactions. Steve Elms's most active month to acquire stocks was the month of May. 2014 was Steve Elms's most active year for disposing of shares, totalling 17 transactions. Steve Elms's most active month to dispose stocks was the month of April. 2011 saw Steve Elms paying a total of $10,000,003.00 for 769,231 shares, this is the most they've acquired in one year. In 2019 Steve Elms cashed out on 2,089,919 shares for a total of $491,130,965.00, their largest year based on trade value.